Berman Howard's most recent trade in Atea Pharmaceuticals Inc was a trade of 164,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atea Pharmaceuticals Inc | Howard Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 164,800 | 164,800 | - | - | Stock Option (Right to Buy) | |
| Coya Therapeutics Inc | Howard Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 150,602 | 150,602 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Howard Berman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 163,663 | 163,663 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Berman Howard | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 189,680 | 189,680 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Howard Berman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 165,000 | 165,000 | - | - | Stock Option (right to buy) |